A study recently published in the New England Journal of Medicine concluded that dutasteride ( Avodart – GlaxoSmithKline), a 5α-reductase inhibitor marketed for treatment of symptomatic benign prostatic…
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):29
A study recently published in the New England Journal of Medicine concluded that dutasteride ( Avodart – GlaxoSmithKline), a 5α-reductase inhibitor marketed for treatment of symptomatic benign prostatic hyperplasia, reduced the risk of prostate cancer over a 4-year period.
Edluar (Meda), a new sublingual tablet formulation of the benzodiazepine receptor agonist zolpidem ( Ambien , and others), has been approved by the FDA for treatment of insomnia.
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):29-30
Edluar (Meda), a new sublingual tablet formulation of the benzodiazepine receptor agonist zolpidem ( Ambien , and others), has been approved by the FDA for treatment of insomnia.
Fentanyl buccal soluble film ( Onsolis – Meda) has been approved by the FDA for treatment of breakthrough pain in adult cancer patients who are already taking and are tolerant to around-the-clock opioid…
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):30-1
Fentanyl buccal soluble film ( Onsolis – Meda) has been approved by the FDA for treatment of breakthrough pain in adult cancer patients who are already taking and are tolerant to around-the-clock opioid therapy. It is designated as a Schedule II controlled substance Two other oral transmucosal formulations of fentanyl are already available for this indication.
L-methylfolate ( Deplin — Pamlab) is a “medical food” marketed for adjunctive use in depression or schizophrenia in patients with suboptimal folate levels. It is available only by prescription.
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):31-2
L-methylfolate ( Deplin — Pamlab) is a “medical food” marketed for adjunctive use in depression or schizophrenia in patients with suboptimal folate levels. It is available only by prescription.
In the Medical Letter article on Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation (2010; 52:23) , the last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1…
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):32
In the Medical Letter article on Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation (2010; 52:23) , the last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1 gram of sodium ferric gluconate (Ferrlecit) as about $600.